Clinical Trials in Austin

Showing 2141-2160 of 13,060 trials

A Study of HBS-201 (Pitolisant Delayed-release)

NCT07051252

The purpose of this study is to assess the tolerability of HBS-201 when starting at a therapeutic dose in adult participants with narcolepsy.

Narcolepsy

Harmony Biosciences Management, Inc.46 participantsStarted May 2025

San Ramon, California, United States • Brandon, Florida, United States • Miami, Florida, United States +12 more locations

COMPLETEDPhase 3< 1 mile

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

NCT05478252

The study compares two semaglutide medicines and looks at how well they control blood sugar levels, in participants with type 2 diabetes (T2D). Participants will either get the currently available semaglutide or the semaglutide which is produced through a new manufacturing process. Participants need to take one injection of semaglutide once a week, on the same day of every week. Participants will have a total of 11 clinic visits and the study will last for about 35 weeks (approximately 8 months).

Diabetes Mellitus, Type 2

Novo Nordisk A/S388 participantsStarted Aug 2022

Gilbert, Arizona, United States • Costa Mesa, California, United States • La Mesa, California, United States +101 more locations

A Study of HBS-201 (Pitolisant Delayed-release)

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

Find Trials by Condition in Austin

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

A Study of Zigakibart in Adults With IgA Nephropathy

A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma